v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (3,290,000) $ 1,697,000 $ (605,000) $ (672,000) $ (1,593,000) $ (1,277,000)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Bad debt recovery         0 (18,000)  
Amortization expense         2,000 0  
Stock-based expense         166,000 0  
Non-cash revenue from digital assets         (191,000) (2,000)  
Unrealized net loss (gain) on digital assets 2,295,000   (31,000)   97,000 (31,000) $ 3,519,000
Realized net loss on sale of digital assets 166,000   0   114,000 0  
Changes in operating assets and liabilities:              
Accounts receivable         133,000 190,000  
Prepaid expenses and other current assets         (9,000) (114,000)  
Other assets         2,000 1,000  
Accounts payable         (6,000) 17,000  
Accrued expenses and other current liabilities         107,000 522,000  
Deferred revenue         (11,000) (5,000)  
Net cash used in operating activities         (1,189,000) (717,000)  
Cash flows from investing activities:              
Purchases of digital assets         (506,000) (1,650,000)  
Proceeds from the sale of digital assets         1,172,000 0  
Investment in Manako Labs, Ltd.         (1,000,000) 0  
Net cash used in investing activities         (334,000) (1,650,000)  
Cash flows from financing activities:              
Proceeds from private placement, net of issuance costs         0 6,925,000  
Net cash provided by financing activities         0 8,197,000  
(Decrease) increase in cash         (1,523,000) 5,830,000  
Cash and cash equivalents at beginning of period   $ 2,258,000   $ 4,965,000 2,258,000 4,965,000 4,965,000
Cash and cash equivalents at end of period 735,000   10,795,000   735,000 10,795,000 2,258,000
Reconciliation of cash and cash equivalents              
Cash 735,000   10,295,000   735,000 10,295,000  
Current certificates of deposit 0   500,000   0 500,000 500,000
Total cash and cash equivalents $ 735,000   10,795,000   735,000 10,795,000 $ 2,258,000
Non-cash investing and financing activities:              
Common warrant issuance         60,000 335,000  
Series F Preferred Stock conversion         0 19,000  
Series F Preferred Stock dividends         8,000 25,000  
Common Stock Warrants [Member]              
Cash flows from financing activities:              
Proceeds from exercise of common stock warrants, net of costs     $ 1,241,000   $ 0 $ 1,272,000